EBV EBNA 2 stimulates CDK9-dependent transcription and RNA polymerase II phosphorylation on serine 5. (Q42487093)

1 November 2017

title

EBV EBNA 2 stimulates CDK9-dependent transcription and RNA polymerase II phosphorylation on serine 5. (English)

1 reference

1 November 2017

1 reference

Bark-Jones SJ

1

1 reference

1 November 2017

Webb HM

series ordinal

2

1 reference

1 November 2017

West MJ

series ordinal

3

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

1 November 2017

1 reference

1 November 2017

volume

25

1 reference

1 November 2017

issue

12

1 reference

1 November 2017

page(s)

1775-1785

1 reference

Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Early events in Epstein-Barr virus infection of human B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Epstein-Barr virus latent gene expression during the initiation of B cell immortalization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Indirect quantification of lipid peroxidation in steroid responsive nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Flavopiridol inhibits P-TEFb and blocks HIV-1 replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

A region of herpes simplex virus VP16 can substitute for a transforming domain of Epstein-Barr virus nuclear protein 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in human leukemia cells (U937) through the mitochondrial rather than the receptor-mediated pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Telomere Repeat Binding Factors TRF1, TRF2, and hRAP1 Modulate Replication of Epstein-Barr Virus OriP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Viral transactivators specifically target distinct cellular protein kinases that phosphorylate the RNA polymerase II C-terminal domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

A cyclin associated with the CDK-activating kinase MO15

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Tat-associated kinase (P-TEFb): a component of transcription preinitiation and elongation complexes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

A novel approach to develop anti-HIV drugs: adapting non-nucleoside anticancer chemotherapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Mechanisms of action of flavopiridol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

PU box-binding transcription factors and a POU domain protein cooperate in the Epstein--Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Characterization of Epstein-Barr virus recombinants with deletions of the BamHI C promoter.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Interactions between the aryl hydrocarbon receptor and P-TEFb. Sequential recruitment of transcription factors and differential phosphorylation of C-terminal domain of RNA polymerase II at cyp1a1 promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

The Epstein-Barr Virus Nuclear Protein 2 Acidic Domain Forms a Complex with a Novel Cellular Coactivator That Can Interact with TFIIE

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Advances in chemotherapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209205

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209205

1 reference

Dimensions Publication ID

1 November 2017

1042402264

0 references

1 reference